Dietary approaches to stop hypertension (DASH) in relation to hyper-triglyceridemic-waist (HTGW) phenotype in Iranian adults Authors: Masoud Pirmoradian, Alireza Parvaresh, Zahra Moradmand, Farnaz Shahdadian, Parisa Rouhani, Sepideh Soltani, Parvane Saneei Published: 2026 ABSTRACT AbstractSeveral studies have revealed a significant link between dietary approaches to stop hypertension (DASH) and the hypertriglyceridemia-waist (HTGW) phenotype, but some others did not. To clarify this association, we conducted a cross-sectional study to explore the connection between DASH diet adherence and HTGW phenotype in Iranian adults. This study was conducted among Iranian adults (n = 528) living in Isfahan. Dietary intakes were assessed via a validated 168-item food frequency questionnaire. Anthropometric indices and biochemical parameters were assessed. Participants with serum triglycerides ≥ 150 mg/dL and enlarged waist circumference were considered individuals with an HTGW phenotype. Individuals in the top tertile of DASH, in comparison to those in the bottom tertile, had lower odds of HTGW in both crude (OR = 0.53; 95% CI: 0.32–0.90) and fully adjusted models (OR = 0.36; 95% CI: 0.16–0.82). In stratified analysis by sex, a protective significant association was observed only in female participants (fully-adjusted model: OR T3 vs. T1 = 0.10, 95% CI: 0.02–0.46). Among DASH components, more consumption of nuts and legumes were related to lower odds of HTGW phenotype (OR = 0.34; 95% CI: 0.16–0.71). This cross-sectional study shows an association between the DASH diet and a lower prevalence of the HTGW phenotype in Iranians, especially in women. Further research is needed to explain the reasons behind this connection and generalize the results to all adult populations.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1038/s41598-026-63814-3.Keywords: Adults, Cross-sectional study, DASH diet, Hypertriglyceridemic waist phenotypeSubject terms: Diseases, Endocrinology, Health care, Medical research, Risk factors Introduction Waist circumference (WC) provides limited insights into fat distribution, particularly regarding subcutaneous and internal fat deposition1. Elevated triglyceride (TG) levels are often linked to problems in fat metabolism, especially in individuals with increased waist sizes2. Therefore, the hypertriglyceridemia-waist (HTGW) phenotype has been proposed, which was characterized by a larger waist and high TG levels3. Prior research highlighted the HTGW phenotype as a valuable indicator of metabolic disorders3 such as hyperinsulinemia4, type II diabetes5, hypertension6, hepatic steatosis7, obstructive sleep apnea8 and cardiovascular diseases (CVDs)3. Several factors might be associated with the HTGW phenotype. Sex-specific genetics might be linked to a higher HTGW phenotype and increase hyperuricemia odds in women, particularly post-menopause, when estrogen protection diminishes9,10. Additionally, lifestyle factors and dietary patterns might be related to metabolic outcome and HTGW phenotype11. A study conducted on men and women in Tehran found that whole-grain consumption was inversely linked with the risk of HTGW phenotype, while refined-grain intake was positively connected12. Dietary Approaches to Stop Hypertension (DASH) diet, which promotes low-sodium foods and high-fruit and vegetable intake, has positively affected weight loss and metabolic health13,14. Research from Iran highlighted that following the DASH diet might help prevent metabolic disorders in overweight and obese populations. Lari and colleagues found that this dietary pattern approach could successfully reduce body fat and blood pressure, although its effect on insulin resistance and blood glucose levels was minimal15. Still, the positive influence of DASH diet on blood lipid profiles was not fully confirmed15. We acknowledge potential inconsistencies in evidence due to sex differences in phenotype expression. Our cross-sectional study aimed to explore the connection between DASH diet adherence and the HTGW phenotype in Iranian adults. Methods and materials Study design and participants This study was conducted in 2021 on a sample of adults in Isfahan, a large city in Iran16. With a 17% prevalence of HTGW among Iranian adults12, a confidence interval (CI) of 95%, and precision (d) of 4%, 339 individuals were required for this study. There was no documented registration system available for randomly selecting Iranian adults; therefore, we had to employ a multistage cluster random sampling method to select 600 adults (from both sexes) aged 20–60 from 20 schools in Isfahan city. Due to high prevalence of COVID-19 pandemic during data collection, 600 eligible participants were invited to join the study. To ensure inclusion of individuals from different socioeconomic statuses and physically active lifestyle, we included all adults employed in the selected schools, such as both male and female teachers, school managers, assistants and those working on computers most of the time. Pregnant or lactating individuals, those with a special diet or with a history of CVDs, stroke, type 1 diabetes, or cancer were not entered into the study. Out of the invited subjects, 543 agreed to participate in our investigation (response rate 90.5%). Each participant was provided with written informed consent. In 2021, the local Ethics Committee of Isfahan University of Medical Sciences approved the study protocol by ethical standards. The study procedure was performed according to the Declaration of Helsinki and STROBE checklist (Supplementary Table 1). Individuals with one of the following criteria were excluded: (1) did not report their dietary intakes (n = 4); (2) reported more than 4200 kcal (over-reporters) or lower than 800 kcal (under-reporters) for total energy intake (in order to decrease misreporting (under/over-reporting)) (n = 3); (3) missed data of their WC measurements (n = 7); and (4) refused blood drawing (n = 1). Finally, 528 eligible adults participated in the analysis. A detailed flowchart of study participants is provided in Supplementary Fig. 1. Evaluation of diet and adherence to DASH diet We evaluated typical dietary intake of individuals using a valid Willett-style semi-quantitative 168-item food frequency questionnaire (FFQ)17. A previous validation study of this FFQ on 132 middle-aged adults showed reasonable associations between FFQ-assessed dietary intakes and those obtained from multiple 24-h nutritional recalls17, with correlation coefficients of 0.55 for total energy, 0.59 for fat, 0.65 for proteins, 0.65 for magnesium, and 0.67 for fiber17. Reliability of the utilized FFQ was evaluated and approved by comparing nutrient intakes obtained from the FFQ on two occasions (one year apart)17. A professional dietitian asked the subjects to fill out this FFQ, indicating the frequency and the amount of food they had eaten in the past year. Household measures were applied to convert reported food consumption into grams per day18. Afterward, data were input into Nutritionist IV software to calculate daily energy intake and nutrient levels. DASH score was estimated by summing up scores of 8 food groups associated with DASH adherence. More adherence to DASH was associated with more intake of fruits, vegetables, whole grains, nuts and legumes, low-fat dairy products, and with low intake of sodium, sugar-sweetened beverages (SSBs), and red and processed meats19. Each food group intake was adjusted for energy intake by the residual method20. Then, all participants were categorized into energy-adjusted quintiles and scored 1–5. The lowest score was assigned to participants in the lowest quintile of fruits, vegetables, whole grains, nuts and legumes, and low-fat dairy products, and the highest quintile of sodium, SSBs, and red and processed meats consumption. The highest score was allocated to participants with the highest quintile of healthy food items and the lowest quintile of unhealthy food items. By summing up all of these scores, a total DASH score (varied from 8 to 40) was estimated for each individual. Assessment of HTGW phenotype Based on a recently published study that has established WC cut-off points for Iranian adults, we have identified the threshold for an enlarged WC as 98 cm for men and 84 cm for women21. These cutoff points have specially been validated to identify and predict metabolic outcomes such as obesity and overweight. Additionally, based on the National Cholesterol Education Program (NCEP) and Adult Treatment Panel III (ATP III) guidelines, a serum TG level of 150 mg/dL or higher was considered hypertriglyceridemia22. WC was measured to the nearest 1 mm using a non-stretchable tape measure. WC was recorded after a normal expiration by measuring halfway between the lower rib margin and the iliac crest without applying pressure to the body surface. WC measurement of each subject was repeated, and the average of two measurements was considered in the analysis. Blood samples were collected after 12 h of fasting; the samples were allowed to clot and then centrifuged to separate the serum. The enzymatic colorimetric method (using glycerol phosphate oxidase) was applied to determine serum TG levels. Assessment of other variables Height and weight were measured while subjects stood wearing minimal clothing and no shoes. Height was measured to the nearest 1 mm using a wall-mounted tape, and weight was assessed by using a body composition analyzer (Tanita MC-780MA, Tokyo, Japan). Body mass index (BMI) was estimated by dividing weight (kg) by the square of the height (m2). A self-reported questionnaire was used to gather data on additional confounders such as age, sex, marital status, education, smoking habits, medical history of diseases, drug intake, and socioeconomic condition. Furthermore, physical activity was measured using a validated International Physical Activity Questionnaire (IPAQ) questionnaire23. In IPAQ data on severity of activity (walking, moderate, and vigorous), frequency of activities in a week, and duration of activity on each day were gathered. Metabolic equivalent tasks (METs) were assigned to walking (3.3), moderate-intensity activities (4.0), and vigorous-intensity activities (8.0). METs, the number of days, and the duration for each were multiplied and summed to yield the total MET score (MET. min/week). Participants were categorized to inactive (< 600 MET. min/week), minimally active (≥ 600 to < 3000 MET. min/week), and health-enhancing physical activity (HEPA) active (≥ 3000 MET. min/week). Statistical analysis Although DASH score was constructed from quintiles, individuals were then distributed in tertiles of DASH score, in order to have adequate sample sizes in each group and to ensure having interpretable categories (high, moderate, low DASH adherence). Then, categorical and continuous variables were compared across DASH tertiles using chi-square test and analysis of variance (ANOVA). Mean ± standard deviation (SD)/ standard error (SE) and percentages were reported for continuous and categorical variables. Analysis of covariance (ANCOVA) was applied to report age, sex, and energy-adjusted dietary intakes of participants across tertiles of DASH. Using binary logistic regression, odds ratios (ORs) for HTGW phenotype across tertiles of DASH were calculated in crude and multivariable-adjusted models. In first model, the effects of age, sex, and energy intake were controlled. Furthermore, education, smoking, physical activity, marital status, socioeconomic condition, and use of lipid-lowering medication were all adjusted in second model. In a sensitivity analysis, the effect of BMI was additionally controlled. Model evaluations were done for all models, and collinearity is reported in Supplemental Table 2. Collinearity was provided as variance inflation factors (VIFs) and tolerance. VIFs lower than 10 and tolerances above 0.1 indicated no multicollinearity issues. Model fit assessment was tested and Hosmer–Lemeshow test was not significant (P = 0.87). First tertile of DASH score was considered as the reference category in all models, ensuring a consistent baseline for comparison. DASH tertiles were treated as a continuous variable in logistic regression models to determine a trend. Possible dose–response relationship was also provided by considering tertiles of DASH score as a continuous variable. Stratified analyses were performed based on sex categories (women vs. men), and interactions were tested via general linear models. Using SPSS software version 26 for all statistical analyses further ensured the accuracy and reliability of our results. P-values less than 0.05 were considered statistically significant, providing a clear threshold for interpretation. Result In total, the current cross-sectional study was performed on 528 adults (287 males and 241 females). Mean age, BMI, serum TG, WC, and DASH score of included participants were 42.59 (± 11.18) years, 26.92 (± 4.42) Kg/m2, 153.24 (± 40.76) mg/dL, 92.65 (± 11.47) cm, and 24.01 (± 4.58), respectively. Among eligible participants, 113 (61 males and 52 females) had an HTGW phenotype. General characteristics and cardiometabolic factors of study participants across tertiles of DASH are provided in Table 1. A significant difference was detected in age (P < 0.001), weight (P = 0.03), height (P = 0.01) and physical activity status (P = 0.03) of participants among tertiles of DASH score. Participants with the highest (vs. lowest) DASH adherence diet were more likely to be older, have lower weight and height and to be more active. No other significant differences were found in other demographic and cardiometabolic variables. Table 1General characteristics and cardiometabolic factors of study participants across tertiles of DASH1.Tertiles of DASH scoreT1 (n = 161)9–21T2 (n = 206)22–26T3 (n = 161)27–37P2DASH score18.62 ± 2.2924.11 ± 1.3429.27 ± 2.12 < 0.001Sex, (%)Male57.85056.50.27Female42.25043.5Age, (year)38.07 ± 9.1342.59 ± 10.8147.12 ± 11.73 < 0.001Weight, (kg)78.13 ± 14.9474.17 ± 13.8175.59 ± 14.830.03Height, (cm)169.38 ± 8.95166.84 ± 8.71166.93 ± 7.730.01BMI, (kg/m2)27.18 ± 4.3726.60 ± 4.3027.07 ± 4.610.40Hip, circumference (cm)105.33 ± 8.42103.77 ± 7.37104.57 ± 8.690.19Waist circumference, (cm)93.71 ± 11.8591.41 ± 10.7793.18 ± 11.880.13Triglycerides, (mg/dL)158.21 ± 43.31152.55 ± 41.67149.17 ± 36.450.13Physical activity, (HEPA) (%)Inactive57.163.746.90.03Minimally active35.429.943.1Active7.56.410Education, (%)Diploma or lower9.311.712.00.69Higher than diploma90.788.388.0Marital status, (%)Single16.341.218.90.35Married82.585.378.6Divorced or widow1.30.52.5Smoking status, (%)Nonsmoker94.593.093.60.92Ex-smoker2.13.73.6Current smoker3.43.22.9Socio-economic condition, (%)Low34.227.534.10.79Moderate31.633.630.8High34.238.935.2Use of lipid-lowering medication, (%)Yes7.55.811.80.11No92.594.288.21 For continuous variables, values are mean ± standard deviation (SD). For categorical variables, values are percentages.2 P-values were obtained from one-way ANOVA and χ2 test for quantitative and categorical variables, respectively. Statistically significant values are shown in bold (P< 0.05).DASH, Dietary approaches to stop hypertension; BMI, Body Mass Index; HEPA, Health-enhancing physical activity. General characteristics and cardiometabolic factors of study participants across tertiles of DASH1. 1 For continuous variables, values are mean ± standard deviation (SD). For categorical variables, values are percentages. 2 P-values were obtained from one-way ANOVA and χ2 test for quantitative and categorical variables, respectively. Statistically significant values are shown in bold (P< 0.05). DASH, Dietary approaches to stop hypertension; BMI, Body Mass Index; HEPA, Health-enhancing physical activity. Nutritional intakes of eligible participants across tertiles of DASH score are shown in Table 2. Individuals in top (vs. bottom) tertile of adherence to DASH diet had a higher intake of carbohydrate, calcium, total fiber, whole grains, fruits, vegetables, low-fat dairy, nuts and legumes. In addition, they consumed lower total energy, fat, saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), red and processed meat, sodium, and sugar-sweetened beverages. Other dietary intakes were not statistically different across tertiles of DASH score. Table 2Dietary intakes (energy, macro/micro nutrients and food groups) of study participants across tertiles of DASH score1.Tertiles of DASH scoreT1 (n = 161)9–21T2 (n = 206)22–26T3 (n = 161)27–37P 2DASH score18.62 ± 2.2924.11 ± 1.3429.27 ± 2.12 < 0.001NutrientEnergy, (kcal)2364.09 ± 54.332138.74 ± 46.702359.23 ± 54.190.01Protein, (gr)80.16 ± 1.3681.01 ± 1.1881.20 ± 1.360.85Carbohydrate, (gr)332.43 ± 3.89345.88 ± 3.36357.35 ± 3.88 < 0.001Fat, (gr)73.10 ± 1.4268.05 ± 1.2364.26 ± 1.42 < 0.001Cholesterol, (mg)288.15 ± 9.51281.47 ± 8.22258.94 ± 9.490.08SFA, (gr)24.31 ± 0.6221.87 ± 0.5420.83 ± 0.62 < 0.001MUFA, (gr)23.95 ± 0.5421.29 ± 0.4620.07 ± 0.53 < 0.001PUFA, (gr)16.40 ± 0.5916.63 ± 0.5114.89 ± 0.590.07Calcium, (mg)823.79 ± 29.55911.53 ± 25.541039.63 ± 26.47 < 0.001Vitamin E, (mg)6.60 ± 0.256.84 ± 0.227.18 ± 0.250.26Total fiber, (gr)16.61 ± 0.4421.15 ± 0.3825.67 ± 0.44 < 0.001Food groupsWhole grains, (gr)26.24 ± 3.9748.73 ± 3.4365.65 ± 3.96 < 0.001Fruits, (gr)410.09 ± 24.37556.66 ± 21.06699.05 ± 24.30 < 0.001Vegetables, (gr)236.71 ± 16.93334.02 ± 14.63453.93 ± 16.88 < 0.001Red and processed meat, (gr)86.89 ± 3.4767.54 ± 3.0047.88 ± 3.46 < 0.001Low-fat dairy, (gr)199.95 ± 20.95239.48 ± 17.31336.87 ± 19.98 < 0.001Nuts and legumes, (gr)37.62 ± 3.0052.21 ± 2.5966.69 ± 2.99 < 0.001Sodium, (mg)4657.98 ± 200.383602.39 ± 173.163106.18 ± 199.81 < 0.001Sugar-sweetened beverages, (gr)70.64 ± 6.7534.26 ± 5.839.18 ± 6.73 < 0.0011 Values are mean ± standard error (SE). Energy intake was adjusted for age and sex; all other values were adjusted for age, sex, and energy intake.2 P-values were obtained from ANCOVA test. Statistically significant values are shown in bold (P< 0.05).DASH, Dietary approaches to stop hypertension; SFA, Saturated fatty acids; MUFA, Monounsaturated fatty acids; PUFA, Polyunsaturated fatty acids. Dietary intakes (energy, macro/micro nutrients and food groups) of study participants across tertiles of DASH score1. 1 Values are mean ± standard error (SE). Energy intake was adjusted for age and sex; all other values were adjusted for age, sex, and energy intake. 2 P-values were obtained from ANCOVA test. Statistically significant values are shown in bold (P< 0.05). DASH, Dietary approaches to stop hypertension; SFA, Saturated fatty acids; MUFA, Monounsaturated fatty acids; PUFA, Polyunsaturated fatty acids. Distribution of different phenotypes of serum TG concentration and WC across tertiles of DASH diet is illustrated in Fig. 1. Distribution of participants with enlarged WC and high TG values (or HTGW) decreased from 29.2% to 18.0% in the first to third tertiles of DASH diet adherence. Although a decreasing trend was observed, the difference was not statistically significant. The distribution of normal WC and normal TG phenotypes was slightly increased across the tertiles of the DASH score. Again, this difference was not statistically significant (P = 0.14). Additionally, participants with enlarged WC and normal TG phenotype had the highest prevalence across DASH tertiles. Distribution of different phenotypes of serum triglycerides concentration and waist circumference (WC) across tertiles of DASH score. Multivariate adjusted ORs and 95% CIs for having an HTGW phenotype across tertiles of DASH score are described in Table 3. Individuals in second and third tertile of adherence to DASH diet, in comparison to first tertile, had 47% lower odds of HTGW (OR T2 vs. T1 = 0.53; 95% CI: 0.33–0.87; OR T3 vs. T1 = 0.53; 95% CI: 0.32–0.90), in the crude model. In second model, after adjustment for potential confounders such as the use of lipid-lowering medication, associations did not materially change and became stronger (OR T2 vs. T1 = 0.43; 95% CI: 0.22–0.86; ORT3 vs. T1 = 0.36; 95% CI: 0.16–0.82). Moreover, each tertile increase of DASH score indicated a significant protective association in crude (OR = 0.72; 95% CI: 0.55–0.94) and multivariate-adjusted model (OR = 0.58; 95% CI: 0.38–0.87). In a sensitivity analysis for BMI adjustment, this association did not change (OR T2 vs. T1 = 0.45; 95% CI: 0.22–0.93; ORT3 vs. T1 = 0.29; 95% CI: 0.12–0.72; OR for each tertile DASH increment = 0.52; 95% CI: 0.34–0.82). Table 3Multivariate adjusted ORs and 95% CIs for HTGW phenotype across tertiles of DASH score1.Tertiles of DASH scoreT1 (n = 161)T2 (n = 206)T3 (n = 161)P-trend2Per 1 tertiles increaseCases473729Crude1.00 (Ref.)0.53 (0.33, 0.87)0.53 (0.32, 0.90)0.020.72 (0.55, 0.94)Model 11.00 (Ref.)0.49 (0.29, 0.82)0.43 (0.24, 0.76)0.010.64 (0.48, 0.86)Model 21.00 (Ref.)0.43 (0.22, 0.86)0.36 (0.16, 0.82)0.010.58 (0.38, 0.87)1All values are odds ratios and 95% confidence intervals. Model 1: Adjusted for age, sex, and energy intake; Model 2: Additionally adjusted for marital status, education, smoking, physical activity, socio-economic condition, and use of lipid-lowering medication.2P-trend was obtained by the use of DASH score tertiles as a continuous rather than categorical variable. Statistically significant values are shown in bold (P< 0.05).OR, odds ratio; CI, confidence interval; HTGW, hyper-triglyceridemic-waist; DASH, dietary approaches to stop hypertension; Ref, reference. Multivariate adjusted ORs and 95% CIs for HTGW phenotype across tertiles of DASH score1. 1All values are odds ratios and 95% confidence intervals. Model 1: Adjusted for age, sex, and energy intake; Model 2: Additionally adjusted for marital status, education, smoking, physical activity, socio-economic condition, and use of lipid-lowering medication. 2P-trend was obtained by the use of DASH score tertiles as a continuous rather than categorical variable. Statistically significant values are shown in bold (P< 0.05). OR, odds ratio; CI, confidence interval; HTGW, hyper-triglyceridemic-waist; DASH, dietary approaches to stop hypertension; Ref, reference. Multivariate-adjusted ORs and 95% CIs for HTGW phenotype across tertiles of DASH score stratified by sex (women vs. men) are reported in Table 4. The prevalence of HTGW was 21.3% in men (61 of 287) and 21.6% in women (52 of 241). In women, in crude model, odds of HTGW phenotype in third tertiles of DASH score were 57% lower than in first tertile (ORT3 vs T1 = 0.43; 95% CI: 0.19–0.97). By considering potential confounders into model, the observed relation became stronger and showed 90% lower odds of HTGW phenotype (ORT3 vs T1 = 0.10; 95% CI: 0.02–0.46). In case of male participants, no significant association between tertiles of DASH score and having an HTGW phenotype was found. Interactions between DASH score and sex in relation to HTGW status was marginally significant (P interaction = 0.05). In a sensitivity analysis, controlling BMI in addition to potential confounders indicated a stronger association in female (ORT3 vs. T1 = 0.11; 95% CI: 0.02–0.55), but no significant association was found in male participants (ORT3 vs T1 = 0.39; 95% CI: 0.12–1.32). Table 4Multivariate adjusted OR and 95% CI for HTGW phenotype across tertiles of DASH score, stratified by sex (women vs. men)1.Tertiles of DASH scoreT1T2T3P-trend2Women (n = 241)Cases/participants (n)22/6818/10312/70Crude1.00 (Ref.)0.44 (0.22, 0.91)0.43 (0.19, 0.97)0.03Model 11.00 (Ref.)0.38 (0.18, 0.80)0.30 (0.13, 0.71)0.01Model 21.00 (Ref.)0.20 (0.06, 0.65)0.10 (0.02, 0.46)0.01Men (n = 287)Cases/participants (n)25/9319/10317/91Crude1.00 (Ref.)0.62 (0.31, 1.21)0.63 (0.31, 1.26)0.17Model 11.00 (Ref.)0.67 (0.32, 1.38)0.63 (0.29, 1.37)0.25Model 21.00 (Ref.)0.72 (0.29, 1.78)0.69 (0.24, 1.95)0.451All values are odds ratios and 95% confidence intervals. Model 1: Adjusted for age, and energy intake; Model 2: Additionally adjusted for marital status, education, smoking, physical activity, socio-economic condition, and use of lipid-lowering medication.2 P-trend was obtained by the use of DASH score tertiles as a continuous rather than categorical variable. Statistically significant values are shown in bold (P< 0.05).OR, odds ratio; CI, confidence interval; HTGW, hyper-triglyceridemic-waist; DASH, dietary approaches to stop hypertension; Ref, reference. Multivariate adjusted OR and 95% CI for HTGW phenotype across tertiles of DASH score, stratified by sex (women vs. men)1. 1All values are odds ratios and 95% confidence intervals. Model 1: Adjusted for age, and energy intake; Model 2: Additionally adjusted for marital status, education, smoking, physical activity, socio-economic condition, and use of lipid-lowering medication. 2 P-trend was obtained by the use of DASH score tertiles as a continuous rather than categorical variable. Statistically significant values are shown in bold (P< 0.05). OR, odds ratio; CI, confidence interval; HTGW, hyper-triglyceridemic-waist; DASH, dietary approaches to stop hypertension; Ref, reference. Multivariate adjusted ORs and 95% CIs for HTGW phenotype across tertiles of components of DASH diet are represented in Table 5. After controlling for potential confounders, the highest consumption of nuts and legumes compared to the lowest intake was related to 66% lower odds of HTGW phenotype (ORT3 vs. T1 = 0.34, 95% CI: 0.16, 0.71). No significant associations were observed among other food groups of DASH diet and HTGW phenotype. In a sensitivity analysis, after controlling for BMI, the highest consumption of fruits as well as nuts and legumes compared to the lowest intake was related to 59% and 70% lower odds of HTGW phenotype (for fruits: ORT3 vs. T1 = 0.41, 95% CI: 0.18, 0.94; for nuts and legumes: ORT3 vs. T1 = 0.30, 95% CI: 0.14, 0.67). Table 5Multivariate adjusted OR and 95% CI for HTGW phenotype across tertiles of components of DASH score1.T1T2T3P-trend2Tertiles of whole grainsCases/participants (n)39/17535/17639/177Crude1.00 (Ref.)0.87 (0.52, 1.45)0.99 (0.60, 1.63)0.96Multivariate adjusted model1.00 (Ref.)0.72 (0.35, 1.46)0.79 (0.39, 1.62)0.52Tertiles of fruitsCases/participants (n)37/17544/17632/177Crude1.00 (Ref.)1.24 (0.76, 2.05)0.82 (0.49, 1.40)0.48Multivariate adjusted model1.00 (Ref.)0.77 (0.39, 1.53)0.59 (0.28, 1.24)0.16Tertiles of vegetablesCases/participants (n)38/17742/17733/174Crude1.00 (Ref.)1.14 (0.69, 1.87)0.86 (0.51, 1.44)0.57Multivariate adjusted model1.00 (Ref.)1.24 (0.62, 2.48)0.75 (0.36, 1.58)0.49Tertiles of red and processed meatCases/participants (n)34/17636/17743/175Crude1.00 (Ref.)1.07 (0.63, 1.80)1.36 (0.82, 2.26)0.23Multivariate adjusted model1.00 (Ref.)1.73 (0.84, 3.62)1.59 (0.76, 3.35)0.24Tertiles of low-fat dairyCases/participants (n)33/17537/17643/177Crude1.00 (Ref.)1.15 (0.68, 1.94)1.38 (0.83, 2.30)0.21Multivariate adjusted model1.00 (Ref.)0.72 (0.33, 1.55)1.39 (0.71, 2.71)0.29Tertiles of nuts and legumesCases/participants (n)51/17636/17726/175Crude1.00 (Ref.)0.63 (0.38, 1.02)0.43 (0.25, 0.73)0.01Multivariate adjusted model1.00 (Ref.)0.58 (0.29, 1.15)0.34 (0.16, 0.71)0.01Tertiles of sodiumCases/participants (n)31/17637/17745/175Crude1.00 (Ref.)1.24 (0.73, 2.10)1.62 (0.97, 2.71)0.07Multivariate adjusted model1.00 (Ref.)1.19 (0.57, 2.46)1.44 (0.71, 2.92)0.30Tertiles of sugar-sweetened beveragesCases/participants (n)36/17631/17846/174Crude1.00 (Ref.)0.82 (0.48, 1.40)1.40 (0.85, 2.30)0.18Multivariate adjusted model1.00 (Ref.)0.82 (0.36, 1.86)1.54 (0.74, 3.22)0.191All values are odds ratios and 95% confidence intervals. Multivariate adjusted model: Adjusted for age, sex, energy intake, marital status, education, smoking, physical activity, socio-economic condition, and use of lipid-lowering medication.2P-trend was obtained by the use of DASH score tertiles as a continuous rather than categorical variable. Statistically significant values are shown in bold (P< 0.05).OR, odds ratio; CI, confidence interval; HTGW, hyper-triglyceridemic-waist; DASH, dietary approaches to stop hypertension; Ref, reference. Multivariate adjusted OR and 95% CI for HTGW phenotype across tertiles of components of DASH score1. 1All values are odds ratios and 95% confidence intervals. Multivariate adjusted model: Adjusted for age, sex, energy intake, marital status, education, smoking, physical activity, socio-economic condition, and use of lipid-lowering medication. 2P-trend was obtained by the use of DASH score tertiles as a continuous rather than categorical variable. Statistically significant values are shown in bold (P< 0.05). OR, odds ratio; CI, confidence interval; HTGW, hyper-triglyceridemic-waist; DASH, dietary approaches to stop hypertension; Ref, reference. Discussion This cross-sectional study involving 528 Iranian adults examined the connection between adherence to DASH diet and having an HTGW phenotype. Notably, the analysis revealed an inverse association between adherence to DASH diet and HTGW phenotype, especially among female adults; such substantially strong association could result from possible residual confounding, selection bias, or sparse-data bias (especially due to small case numbers in the top tertile; in the female subgroup, the distribution of cases across tertiles 1–3 was 22, 18, and 12, respectively). The HTGW phenotype offers superior predictive validity compared to WC or TG alone for key cardiometabolic outcomes. While WC identifies visceral adiposity and elevated TG signals dyslipidemia, their combination can more effectively capture synergistic central obesity and dyslipidemia than a single measure. HTGW phenotype has been associated with various metabolic disorders and non-communicable diseases, including type II diabetes mellitus1, hypertension6,24, non-alcoholic fatty liver disease (NAFLD)25, and CVDs3,26. Based on results of the current investigation, adopting the DASH diet might be associated with a decrease in the HTGW phenotype and consequences. In Iran, dyslipidemia affects a significant portion of adult population, with an overall prevalence of 81.0%. This condition is even more prevalent among women (84.4%) than men (75.7%)27. Additionally, about 32.3% of Iranian women have been classified as obese, with an even higher percentage (81.4%) suffering from abdominal obesity28. Rates of obesity and abdominal obesity among men have been notably lower (15.1% and 68.6%, respectively)28. The prevalence of HTGW in our population was 21.4%, comparable to findings from other studies in Iran. For instance, a previous cross-sectional study among Iranian adults reported a prevalence of 17.1%12. In contrast, another study on women identified 36.4% of them as individuals with the HTGW phenotype, likely reflecting sex-specific differences in fat distribution and triglyceride metabolism29. Among Iranian adolescents, this prevalence was notably lower at 3.3%, highlighting the age-related progression of this cardiometabolic marker30. To our knowledge, no studies have directly examined the association of the DASH diet and the HTGW phenotype. However, the association of the DASH diet and waist circumference was addressed. Association between adherence to DASH dietary pattern and lipid profiles was additionally evaluated in several previous investigations, but contradictory results were provided. In line with our findings, a meta-analysis of randomized controlled clinical trials has suggested that the DASH diet is a good choice for weight reduction among individuals with overweight or obesity31. In contrast to our findings, a meta-analysis indicated that DASH diet could enhance the lipid profile (total cholesterol, low-density lipoprotein cholesterol, and very low-density lipoprotein cholesterol levels), but not TG levels32. A large population-based study conducted back in 1980 on 88,517 female nurses without a history of diabetes or CVDs found that there was not a meaningful link between DASH scores and their serum lipid levels19. A randomized clinical trial on forty participants with NAFLD suggested that greater adherence to DASH diet might yield more significant improvements in obesity, atherogenic markers, and liver steatosis than a typical low-calorie diet. However, it did not significantly impact serum high-density lipoprotein cholesterol (HDL-c), TG/HDL-c, and oxidative stress levels33. A retrospective cohort study conducted in 2022 on 14,251 participants revealed that individuals with an HTGW phenotype were particularly adults with higher age and overweight or obesity, and faced a greater susceptibility to NAFLD25. Gender differences highlighted that women with an HTGW phenotype were at a rising risk of developing NAFLD compared to their male counterparts. Similar gender disparities have been documented in other research exploring the relationship between HTGW and various diseases, including type II diabetes25. The observed gender difference might be rooted in biological, cardiovascular risk stratification34, active lifestyle and socioeconomic factors35. Over 2800 genes differentially expressed in men and women could lead to larger fat cell sizes of the intraabdominal in men and subcutaneous depots in women36. Another relevant cohort study published in 2018 explored the association between different triglyceride-glucose (TyG)-related indices and risk of all-cause and cause-specific mortality among the MetS population37. TyG-WC was a significant predictor of cardiovascular mortality in this population. All TyG-related indices were also shown to have strong associations with diabetes mortality among individuals with MetS37. It is worth noting that the observed inconsistencies among prior studies might be attributed to differences in study populations, study designs, the components considered for DASH diet adherence, and the statistical adjustments applied. Several mechanisms might influence this relationship. DASH diet incorporates nutrient-rich foods like fruits, vegetables, and whole grains, which can help reduce central obesity—a key factor connected to an HTGW phenotype. Interestingly, this benefit tends to be more noticeable in women, mainly because they usually have a higher body fat percentage and lower visceral fat due to estrogen effects. Additionally, hormonal changes during menopause can make women even more vulnerable to metabolic disorders, highlighting the importance of healthy eating during this life stage38–40. However, the reasons for these discrepancies in findings in women vs. men still need to be understood entirely. Factors such as the renin-angiotensin system, sex hormones, sex-specific genes, and elevated inflammatory markers may explain the observed differences in dietary intake between women and men39. For instance, the response to stimulation of the renin–angiotensin–aldosterone system (RAAS) may differ by gender. Nutrient profile of DASH diet—rich in potassium, calcium, magnesium, and fiber—has been suggested to improve visceral obesity, lipid profiles, and reduce insulin resistance, via reduced glycemic load, antioxidants, and lower refined carbohydrate41. Potassium plays critical role in RAAS modulation which reduces systemic inflammation and improves insulin sensitivity42. Dietary fiber in DASH diet reduces dietary glycemic load and synthesis of hepatic VLDL by inhibition of hepatic lipogenesis and reducing delivery of free fatty acids to the liver33,41,43. In our study, the DASH diet and the HTGW phenotype were associated with different outcomes in men and women. However, the cross-sectional nature of this investigation made it challenging to establish a causal connection. Probably, individuals with obesity and high TG might adopt the DASH diet post-diagnosis to lose weight. On the other hand, those with subclinical HTGW might unconsciously reduce physical activity and alter food preparation methods (such as increased frying and fast-foods), which create bidirectional relationships. In addition, the exposure and outcome were measured simultaneously, temporality cannot be established and reverse causation cannot be excluded. Well-designed studies are necessary to determine causality. Additionally, although validated questionnaires (FFQ for dietary intake and IPAQ for physical activity) and standardized assessment of confounders were used, recall and other potential reporting biases and measurement errors were unavoidable and may have impacted the results. In addition, self-reported IPAQ might not give the most reliable data, although the daily activity included in this analysis would be a good inclusion to evaluate the relationship between DASH and HTGW. It is also important to note that while many confounding factors were controlled for in this study, any potential influence of residual confounders should still be considered. Such residual confounding could lead to overestimation or exaggeration of the true relationship that was observed in the female subgroup. Total energy intake is an important dietary variable and its association with HTGW phenotype may be partly explained by other dietary and lifestyle factors. Total energy intake in the second tertile was lower than the first and third tertile, but OR for energy intake in fully adjusted model indicated that energy did not influence HTGW independently (OR = 1.02; 95% CI: 0.98- 1.05; P = 0.35). However, independent association between total energy intake and HTGW should be confirmed in future studies and other populations. No documented health care system for registering Iranian adults was available. Therefore, schools were randomly selected, and all adults working in schools were included to represent diversity in socioeconomic status and physically active lifestyle. On the other hand, including some sedentary occupations, such as those working in offices, working on computers most of the time, managers, or administrators who were in meetings might result in some biases in the findings. Despite the application of this multi-cluster random sampling, there was a possibility of selection bias, and the external validity and generalizability of the results may be restricted. These limitations emphasize the necessity for further longitudinal studies to enhance understanding of the underlying causes and address potential biases. Our findings indicated an inverse association between DASH diet and the HTGW phenotype, mainly among Iranian women. These results might inform dietary recommendations for the DASH diet associated with addressing the HTGW phenotype within the Iranian community. Given the current limitations, further studies with larger populations are required to understand this association and confirm these findings. Supplementary Information Supplementary Information. Acknowledgements None. Abbreviations Analysis of variance Analysis of covariance Adult Treatment Panel III Body mass index Confidence interval Cardiovascular disease Dietary approaches to stop hypertension Food frequency questionnaire Hypertriglyceridemia-waist Metabolic syndrome Standard deviation Standard error Sugar-sweetened beverages National Cholesterol Education Program International Physical Activity Questionnaire Monounsaturated fatty acids Non-alcoholic fatty liver disease Saturated fatty acids Triglyceride-glucose Waist circumference Author contributions MP and AP: Conceptualization, Methodology, Formal analysis, Funding acquisition, Writing-original draft. ZM: Investigation, Writing-original draft. FS: Investigation and Data Curation. PR: Investigation and Data Curation. SS and PS: Conceptualization, Methodology, Supervision, Resource, Formal analysis, Funding acquisition, Writing-editing and reviewing. All authors approved the final version of the manuscript and agreed on all aspects of the work. Funding The financial support for conception, design, data analysis, and manuscript drafting comes from Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran (no. 2404160). Data availability The data that support the findings of this study are available from the corresponding author upon reasonable request. Declarations Competing interests The authors declare that they have no competing interests. Ethical approval and consent to participate The study protocol was approved by the local Ethics Committee of Isfahan University of Medical Sciences in 2021. All participants provided informed written consent. The study was conducted in accordance with the Declaration of Helsinki and STROBE guidelines. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Sepideh Soltani, Email: s.soltani1979@yahoo.com. Parvane Saneei, Email: saneei@nutr.mui.ac.ir. References Associated Data Supplementary Materials Supplementary Information. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.